SYS6002 vs Chemotherapy in Recurrent or Metastatic Cervical Cancer

NCT07230626 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

412

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Cancer

Interventions

DRUG: SYS6002
DRUG: Investigator's Choice of Chemotherapy

Sponsor

CSPC Megalith Biopharmaceutical Co.,Ltd.